Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
BMC Cancer|August 31, 2017
Distinct preoperative clinical features predict four histopathological subtypes of high-grade serous carcinoma of the ovary, fallopian tube, and peritoneumTakuma Ohsuga, Ken Yamaguchi, Aki Kido, et al.
BMC Cancer|October 29, 2014
Clinical approaches to treating papillary squamous cell carcinoma of the uterine cervixMichikazu Nagura, Masafumi Koshiyama, Noriomi Matsumura, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 24, 2018
A Predictor of Tumor Recurrence in Patients With Endometrial Carcinoma After Complete Resection of the Tumor: The Role of Pretreatment Apparent Diffusion CoefficientRyo Kuwahara, Aki Kido, Shiro Tanaka, et al.
BMC Cancer|October 21, 2015
Genomic profile predicts the efficacy of neoadjuvant chemotherapy for cervical cancer patientsNaoki Horikawa, Tsukasa Baba, Noriomi Matsumura, et al.
The Oncologist|August 31, 2018
Antitumor Effect of Nivolumab on Subsequent Chemotherapy for Platinum-Resistant Ovarian CancerYoshihide Inayama, Junzo Hamanishi, Noriomi Matsumura, et al.
Cancer Science|August 31, 2021
PDK2 leads to cisplatin resistance through suppression of mitochondrial function in ovarian clear cell carcinomaSachiko Kitamura, Ken Yamaguchi, Ryusuke Murakami, et al.
Journal of Gynecologic Oncology|August 29, 2022
Peritoneal dissemination of high-grade serous ovarian cancer: pivotal roles of chromosomal instability and epigenetic dynamicsIkuo Konishi, Kaoru Abiko, Takuma Hayashi, et al.
In Vivo (Athens, Greece)|August 28, 2025
Robotic Versus Laparoscopic Pelvic Lymphadenectomy for Endometrial Cancer Under the Japanese Public Health Insurance SystemHikaru Imatake, Kana Kawai, Yuka Matsumoto, et al.
Oncotarget|August 31, 2015
Metabolic alterations caused by HNF1β expression in ovarian clear cell carcinoma contribute to cell survivalYasuaki Amano, Masaki Mandai, Ken Yamaguchi, et al.
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|February 16, 2017
Combination of Aprepitant, Azasetron, and Dexamethasone as Antiemetic Prophylaxis in Women with Gynecologic Cancers Receiving Paclitaxel/Carboplatin TherapyMasafumi Koshiyama, Noriomi Matsumura, Saeko Imai, et al.
Pageof 10